Sharkey Howes & Javer Acquires 135 Shares of Thermo Fisher Scientific Inc. (TMO)

Sharkey Howes & Javer boosted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 27.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 623 shares of the medical research company’s stock after acquiring an additional 135 shares during the period. Sharkey Howes & Javer’s holdings in Thermo Fisher Scientific were worth $171,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also modified their holdings of TMO. Vanguard Group Inc lifted its position in shares of Thermo Fisher Scientific by 1.2% during the third quarter. Vanguard Group Inc now owns 29,271,095 shares of the medical research company’s stock valued at $7,144,489,000 after buying an additional 347,836 shares during the last quarter. BlackRock Inc. lifted its position in shares of Thermo Fisher Scientific by 3.7% during the fourth quarter. BlackRock Inc. now owns 26,177,278 shares of the medical research company’s stock valued at $5,858,214,000 after buying an additional 944,035 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its position in shares of Thermo Fisher Scientific by 44,296.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 19,565,960 shares of the medical research company’s stock valued at $87,000 after buying an additional 19,521,889 shares during the last quarter. FMR LLC lifted its position in shares of Thermo Fisher Scientific by 33.4% during the fourth quarter. FMR LLC now owns 8,671,713 shares of the medical research company’s stock valued at $1,940,642,000 after buying an additional 2,172,574 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Thermo Fisher Scientific by 9.4% during the fourth quarter. Geode Capital Management LLC now owns 4,897,714 shares of the medical research company’s stock valued at $1,094,013,000 after buying an additional 422,625 shares during the last quarter. Institutional investors own 88.66% of the company’s stock.

In related news, CAO Peter E. Hornstra sold 5,920 shares of the stock in a transaction that occurred on Friday, February 15th. The shares were sold at an average price of $250.00, for a total value of $1,480,000.00. Following the completion of the transaction, the chief accounting officer now directly owns 17,057 shares of the company’s stock, valued at approximately $4,264,250. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Gregory J. Herrema sold 5,400 shares of the stock in a transaction that occurred on Tuesday, February 19th. The shares were sold at an average price of $251.51, for a total transaction of $1,358,154.00. Following the completion of the transaction, the senior vice president now directly owns 31,846 shares of the company’s stock, valued at $8,009,587.46. The disclosure for this sale can be found here. Insiders sold a total of 36,927 shares of company stock valued at $9,388,124 over the last ninety days. 0.49% of the stock is currently owned by insiders.

Shares of Thermo Fisher Scientific stock opened at $259.78 on Friday. The company has a market capitalization of $103.65 billion, a P/E ratio of 23.36, a P/E/G ratio of 1.71 and a beta of 1.13. The company has a quick ratio of 1.24, a current ratio of 1.73 and a debt-to-equity ratio of 0.64. Thermo Fisher Scientific Inc. has a 52 week low of $202.83 and a 52 week high of $282.98.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, January 30th. The medical research company reported $3.25 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.19 by $0.06. The firm had revenue of $6.51 billion during the quarter, compared to analyst estimates of $6.26 billion. Thermo Fisher Scientific had a net margin of 12.06% and a return on equity of 16.86%. Thermo Fisher Scientific’s revenue was up 7.6% on a year-over-year basis. During the same period last year, the firm posted $2.79 EPS. Analysts expect that Thermo Fisher Scientific Inc. will post 12.16 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 16th. Investors of record on Friday, March 15th were given a $0.19 dividend. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.29%. The ex-dividend date was Thursday, March 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 6.83%.

Several analysts have commented on TMO shares. UBS Group increased their price target on shares of Thermo Fisher Scientific to $305.00 and gave the company a “buy” rating in a research report on Monday, March 25th. BTIG Research increased their price target on shares of Thermo Fisher Scientific to $290.00 and gave the company a “buy” rating in a research report on Thursday, January 31st. Barclays increased their price target on shares of Thermo Fisher Scientific from $295.00 to $300.00 and gave the company an “overweight” rating in a research report on Monday, March 18th. Needham & Company LLC started coverage on shares of Thermo Fisher Scientific in a research report on Wednesday, January 2nd. They set a “strong-buy” rating and a $271.00 price target for the company. Finally, Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Saturday, January 5th. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. Thermo Fisher Scientific has an average rating of “Buy” and an average price target of $289.92.

WARNING: “Sharkey Howes & Javer Acquires 135 Shares of Thermo Fisher Scientific Inc. (TMO)” was first reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.baseballdailydigest.com/news/2019/04/21/sharkey-howes-javer-acquires-135-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Recommended Story: What are the advantages of the Stochastic Momentum Index?

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.